AGE-DEPENDENT CHANGES IN SYNAPTIC RAFT DOMAINS AND PLASMA MEMBRANE CA2+ - ATPASE
突触筏域和质膜 CA2 - ATP酶的年龄依赖性变化
基本信息
- 批准号:7347339
- 负责人:
- 金额:$ 25.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAgingAlzheimer&aposs DiseaseAntibodiesBindingBrainCa(2+)-Transporting ATPaseCalmodulinCell membraneCell modelCellsCeramidesCholesterolChronicCognitiveComplexCultured CellsDataDementiaDetergentsDiseaseDisruptionElderlyEnvironmentEnzymesExperimental ModelsFluorescenceGangliosidesGlycosphingolipidsGoalsHomeostasisImageImmunoprecipitationImpaired cognitionIn SituIn VitroInterventionKineticsLinkLipid PeroxidationLipidsLocalizedManagement Information SystemsMembraneMembrane MicrodomainsModelingModificationMolecularMolecular BiologyNerve DegenerationNeurodegenerative DisordersNeuronsOxidative StressParkinson DiseasePathologic ProcessesPerformancePlayPopulationPredispositionPreparationPrincipal InvestigatorPrion DiseasesProcessPropertyProteinsRNA InterferenceRattusRegulationRelative (related person)ResistanceRoleSamplingSignal TransductionSiteSphingolipidsStressStructureSynapsesSynaptic MembranesSynaptosomesTechniquesTestingTranscriptional ActivationUp-RegulationVariantage relatedagedaging brainbrain cellbrain tissueenzyme activityexcitotoxicitygenetic manipulationin vivoinsightintracellular protein transportmacromoleculemiddle ageoxidationpreventprogramsprotein localization locationresearch studysarcopenia
项目摘要
Mechanisms underlying the age-related decline in cognitive performance and increased susceptibility to
neurodegenerative diseases are not known, though dysregulation of Ca2+ homeostasis and enhanced
oxidative stress appear to be primary contributors. We have found that a major Ca2+ regulator, the plasma
membrane Ca2+ -ATPase (PMCA), is uniquely sensitive to oxidation and is progressively lost from specific
membrane domains of brain neurons with age. These 'raft' domains create platforms for Ca2+- signaling and
are also known to be sites for the processing of the abnormal proteins associated with neurodegenerative
diseases. The overall goal of this project is to identify the mechanisms that regulate the localization
of PMCA in raft domains and the age-dependent changes underlying the loss of PMCA activity from
rafts. Our hypothesis is that this loss is due to enhanced oxidative stress that leads to agedependent
changes in the proteins and lipids that regulate the activity and localization of PMCA
within rafts. The Aims of this application are to: (1) characterize synaptic membrane rafts from 5, 22 and 34-
mos F344/BNF1 rats in terms of protein and lipid oxidation, raft lipid composition, and effects of in vitro
oxidative stress; (2) use pharmacological and genetic manipulations to elucidate the role of the raft lipid
environment in the membrane localization and kinetic properties of PMCA; (3) determine the role of protein
interactions in localization of PMCA in rafts by identifying PMCA binding partners in raft vs non-raft domains,
determining their levels in membranes from 5, 22, and 34-mos rats, and altering expression of the major
partners in cells to test directly their effects on PMCA localization and activity. Our strategy involves analysis
of in vivo brain aging in parallel with in vitro neuronal models for testing specific mechanisms that may
explain some of the age-dependent alterations. We make extensive use of expertise in lipidomics, protein
identification, and molecular biology available in the Cores, and preliminary data support the feasibility of all
aims. Despite the evidence for involvement of rafts in Ca2+ signaling and for Ca2+ dysregulation in agedependent
neurodegenerative diseases, nothing is known about aging in neuronal rafts. Our studies will
begin to fill that gap and provide new insights into links between aging, altered Ca2+ disposition, oxidative
stress and the enhanced vulnerability of the aging brain to the devastating dementias that affect elderly
populations.
Lav Statement: The proposed studies will enhance our understanding of changes that occur in the aging
brain that make it so vulnerable to cognitive impairment and diseases such as Alzheimer's. The ultimate
goal is to identify what interventions might slow or prevent some of those changes with advancing age.
与年龄相关的认知能力下降和易感性增加的机制
神经退行性疾病尚不清楚,但 Ca2+ 稳态失调和增强
氧化应激似乎是主要因素。我们发现,血浆是一个主要的 Ca2+ 调节剂
膜 Ca2+ -ATP 酶 (PMCA) 对氧化特别敏感,并且会因特定的作用而逐渐丢失
随着年龄的增长,大脑神经元的膜域。这些“筏”结构域为 Ca2+- 信号传导和
还已知是处理与神经退行性疾病相关的异常蛋白质的位点
疾病。该项目的总体目标是确定调节本地化的机制
筏域中 PMCA 的含量以及 PMCA 活性丧失背后的年龄依赖性变化
木筏。我们的假设是,这种损失是由于氧化应激增强导致年龄依赖性
调节 PMCA 活性和定位的蛋白质和脂质的变化
筏内。本申请的目的是:(1) 表征 5、22 和 34-突触膜筏
mos F344/BNF1 大鼠的蛋白质和脂质氧化、筏脂质组成以及体外影响
氧化应激; (2)利用药理学和遗传学操作来阐明筏脂质的作用
PMCA的膜定位和动力学特性中的环境; (3)确定蛋白质的作用
通过识别筏域和非筏域中的 PMCA 结合伙伴,在筏中 PMCA 定位中的相互作用,
确定它们在 5、22 和 34 个月大鼠膜中的水平,并改变主要的表达
细胞中的合作伙伴直接测试它们对 PMCA 定位和活性的影响。我们的策略涉及分析
与体外神经元模型并行地研究体内脑老化,以测试可能的特定机制
解释一些与年龄相关的变化。我们广泛利用脂质组学、蛋白质组学方面的专业知识
核心中提供的鉴定和分子生物学,以及初步数据支持所有的可行性
目标。尽管有证据表明筏参与 Ca2+ 信号传导以及年龄依赖性的 Ca2+ 失调
神经退行性疾病,但我们对神经元筏的衰老一无所知。我们的研究将
开始填补这一空白,并为衰老、Ca2+分布改变、氧化之间的联系提供新的见解
压力以及老化大脑对影响老年人的毁灭性痴呆症的脆弱性增强
人口。
Lav声明:拟议的研究将增强我们对衰老过程中发生的变化的理解
大脑很容易受到认知障碍和阿尔茨海默氏症等疾病的影响。终极
目标是确定哪些干预措施可以减缓或防止随着年龄增长而发生的一些变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY L. MICHAELIS其他文献
MARY L. MICHAELIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY L. MICHAELIS', 18)}}的其他基金
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
新型 Hsp90 抑制剂可减少阿尔茨海默病中的错误折叠蛋白
- 批准号:
7351215 - 财政年份:2008
- 资助金额:
$ 25.23万 - 项目类别:
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
新型 Hsp90 抑制剂可减少阿尔茨海默病中的错误折叠蛋白
- 批准号:
7612113 - 财政年份:2008
- 资助金额:
$ 25.23万 - 项目类别:
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
新型 Hsp90 抑制剂可减少阿尔茨海默病中的错误折叠蛋白
- 批准号:
7796649 - 财政年份:2008
- 资助金额:
$ 25.23万 - 项目类别:
ANIMAL MODELS, ELECTRON MICROSCOPY, CELL CULTURE AND MOLECULAR BIOLOGY
动物模型、电子显微镜、细胞培养和分子生物学
- 批准号:
7347337 - 财政年份:2008
- 资助金额:
$ 25.23万 - 项目类别:
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
新型 Hsp90 抑制剂可减少阿尔茨海默病中的错误折叠蛋白
- 批准号:
8195513 - 财政年份:2008
- 资助金额:
$ 25.23万 - 项目类别:
In Vivo Testing of Microtubule-Stabilizing Drugs in Triple Transgenic Mice
三重转基因小鼠体内微管稳定药物测试
- 批准号:
7229906 - 财政年份:2006
- 资助金额:
$ 25.23万 - 项目类别:
University of Kansas/Haskell Indian Nations University IRCDA Project
堪萨斯大学/哈斯克尔印第安民族大学 IRCDA 项目
- 批准号:
7477119 - 财政年份:2002
- 资助金额:
$ 25.23万 - 项目类别:
CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODIES
核心——组织培养和单克隆抗体
- 批准号:
6650623 - 财政年份:2002
- 资助金额:
$ 25.23万 - 项目类别:
University of Kansas/Haskell Indian Nations University IRCDA Project
堪萨斯大学/哈斯克尔印第安民族大学 IRCDA 项目
- 批准号:
7662335 - 财政年份:2002
- 资助金额:
$ 25.23万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
A2E老化ARMS2/HTRA1型iPSC-RPE细胞的研究:个体化AMD发病机制初步探索
- 批准号:81400412
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 25.23万 - 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 25.23万 - 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 25.23万 - 项目类别:
A National NHP Embryo Resource of Human Genetic Disease Models
国家NHP人类遗传病模型胚胎资源
- 批准号:
10556087 - 财政年份:2023
- 资助金额:
$ 25.23万 - 项目类别: